A real-world retrospective observational study exploring NHS resource use in England for the management of moderate-to-severe atopic dermatitis in secondary care for children and adolescents.

Tess McPherson Michael J Cork Charlotte Goodhead Louise Jane Michaelis Carsten Flohr Milos Petrovic Liz Hennessy Ivana Rajkovic Richard Hudson

Published in: Pediatric dermatology (2022)

Children and adolescents with moderate-to-severe AD had a high HCRU burden and small changes in quality of life, indicating that current treatments may provide suboptimal AD control in most cases.

Keyphrases

atopic dermatitis
high intensity
early onset
healthcare
palliative care
patient safety
quality improvement
cross sectional
drug induced
risk factors
health insurance